Cogentus Pharmaceuticals

Cogentus Pharmaceuticals is a company focused on developing prescription pharmaceutical products in North America and Europe.

Business Model:

Revenue: $0

Employees: 11-50

Rankings

Detailed Cogentus Pharmaceuticals Information

Geographic Data

Cogentus Pharmaceuticals headquarters map

Address:

City: Menlo Park

State: California

Zip:

Country: United States

Financial Info

Stage:

series c

Raised Last:

$63M

Raised Total:

$78M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Cogentus Pharmaceuticals, Inc., a pharmaceutical company, develops prescription pharmaceutical products in North America and Europe. It develops CGT-2168, an oral formulation that combines clopidogrel with a gastroprotectant, which reduces the gastrointestinal side effects associated with dual antiplatelet therapy. The company was founded in 2006 and is based in Menlo Park, California. On January 16, 2009, Cogentus Pharmaceuticals, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research